Small Cell Lung Cancer

The AJMC^® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.

Latest News

Digitally generated lungs held by doctor | Image credit: Image credit: PRASANNAPIX - stock.adobe.com

Chemo Plus IO Offers Survival Benefit in ES-SCLC vs Chemo Alone in Real-World Study

By AJMC Contributor

April 29th 2025

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung cancer (ES-SCLC).

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

By AJMC Contributor

April 23rd 2025

OS was the primary end point in the trial, and data from the planned interim analysis will be presented at an upcoming scientific meeting. | Image credit: Crystal light - stock.adobe.com

Tarlatamab Improves Overall Survival in Extensive-Stage SCLC

By Jared Kaltwasser

April 14th 2025

The new study suggests LTF should be considered as a potential biomarker of first-line treatment response in patients with ES-SCLC. | Image credit: appledesign - stock.adobe.com

Baseline LTF Linked With Treatment Response in SCLC

By Jared Kaltwasser

April 8th 2025

Doctor showing patient x-ray of lung cancer. | Image credit: Nattakorn – stock.adobe.com

3 DDR Phenotypes May Predict Chemotherapy Response in SCLC

By Hayden E. Klein

March 25th 2025

Multidisciplinary Approaches to Paraneoplastic LEMS

Hear from medical experts as they explore the connection between Lambert-Eaton myasthenic syndrome and small cell lung cancer, discussing diagnostic challenges, economic impacts, and strategies for optimizing care.

Visit Now

...

6 7 8 9 10

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions